NEW YORK (GenomeWeb News) – Agilent Technologies reported after the close of the market on Monday that fiscal second-quarter revenues rose 3 percent year over year while revenues for its Life Sciences segment increased 1 percent.

Total revenues for the three months ended April 30 increased to $1.73 billion from $1.68 billion a year ago, beating Wall Street estimates of $1.71 billion. Total orders increased 8 percent to $1.84 billion during the quarter from $1.70 billion a year ago.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.